Cargando…
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management
While chronic obstructive pulmonary disease (COPD) continues to be a major cause of morbidity and mortality, pharmacological therapy has a definite benefit on symptoms as well as the frequency and severity of exacerbations, and general health. The most recent Global Initiative for Obstructive Lung D...
Autores principales: | Micheletto, Claudio, Braido, Fulvio, Contoli, Marco, Di Marco, Fabiano, Santus, Pierachille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765263/ https://www.ncbi.nlm.nih.gov/pubmed/31576115 http://dx.doi.org/10.2147/COPD.S216059 |
Ejemplares similares
-
Effects of aclidinium on determinants of COPD severity: symptoms and quality of life
por: Contoli, Marco, et al.
Publicado: (2016) -
Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021) -
Disease awareness in patients with COPD: measurement and extent
por: Baiardini, Ilaria, et al.
Publicado: (2018) -
Day and Night Control of COPD and Role of Pharmacotherapy: A Review
por: Braghiroli, Alberto, et al.
Publicado: (2020) -
Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019)